Table 3.
Comparison of socio-demographic and clinical characteristics of patients with and without rheumatic manifestations
| Variable | Rheumatic | No rheumatic | p-value | OR | 95% CI |
| manifestation | manifestation | ||||
| % (N = 81) | % (N=219) | ||||
| Female | 61.7 (50) | 70.3 (154) | 0.157 | 0.68 | 0.4 – 1.16 |
| History of rheumatic | 6.2 (5) | 100 (0) | 0.001 | 1.07 | 1.01 – 1.13 |
| disease | |||||
| Current treatment | |||||
| Septrin | 26.2 (34) | 73.8 (96) | 0.794 | 0.93 | 0.55–1.55 |
| Anti-tuberculosis drugs | 56.3 (9) | 43.8 (7) | 0.016 | 3.79 | 1.44–9.94 |
| Triomune (D4T,3TC,NVP) | 22.7 (10) | 77.3 (34) | 0.583 | 0.77 | 0.36–1.63 |
| Combivir (AZT, 3TC) & | 16.7 (3) | 83.3 (15) | 0.416 | 0.52 | 0.15–1.82 |
| Efavirenz | |||||
| Pallor | 24.1 (7) | 15.4 (10) | 0.175 | 1.98 | 0.73–5.38 |
| Lymph nodes | 6.9 (2) | 9.2 (6) | 0.897 | 0.90 | 0.19–4.38 |
| Pitting oedema | 13.8 (4) | 3.1(2) | 0.027 | 5.41 | 1.01–28.96 |
| Oral ulcers | 21.0(6) | 20.0(13) | 0.642 | 1.25 | 0.49–1.92 |
| Skin lesions | 25.6 (8) | 37.0 (24) | 0.787 | 0.90 | 0.42–1.92 |
| Digital clubbing | 3.45(1) | 1.5(1) | 0.462 | 2.70 | 0.17– 42.72 |
| Lung crepitations | 0 (0) | 7.7 (5) | 0.170 | 1.02 | 1.003 – 1.04 |
| Splenomegaly | 3.45 (1) | 6.2 (4) | 0.722 | 0.68 | 0.08 – 5.96 |